3-[(2R)-Oxiran-2-yl]pyridine

Catalog No.: 
ACWUAQ156
CAS No.: 
174060-40-3
Molecular Formula: 
C7H7NO
Molecular Weight: 
121.14
3-[(2R)-Oxiran-2-yl]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$277.00InquiryInquiry
1g95%$792.00InquiryInquiry
5g95%$3881.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[(2R)-Oxiran-2-yl]pyridine
IUPAC Name(R)-3-(oxiran-2-yl)pyridine
MDL No.MFCD25993930
Molecular FormulaC7H7NO
Molecular Weight121.14
SMILESC1([C@H]2OC2)=CC=CN=C1
InChI KeyQLGZSSLYMJHGRQ-ZETCQYMHSA-N
SynonymPyridine, 3-(2R)-oxiranyl- (9CI);3-[(2R)-oxiranyl]pyridine;Pyridine, 3-(2R)-2-oxiranyl-;3-[(2R)-oxiran-2-yl]pyridine
CAS No.174060-40-3

Safety Data

Pictogram
CorrosiveHealth hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H312-H315-H319-H350
Precautionary Statement(s)
P201-P202-P210-P261-P264-P271-P280-P302+P352+P312-P305+P351+P338-P308+P313-P337+P313-P370+P378-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWUAQ156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJSDN037 route compound structure diagram
    ACJSDN0377789-46-0In Stock
  2. Plus
  3. ACCLYW394 route compound structure diagram
    ACCLYW394112022-83-0In Stock
  4. Plus
  5. ACBJYE857 route compound structure diagram
    ACBJYE8576221-12-1In Stock
  6. Then
  7. ACWUAQ156 route product structure diagram
    ACWUAQ156174060-40-3
Inquiry

2. ACWUAQ156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWUAQ156 route product structure diagram
    ACWUAQ156174060-40-3
Inquiry

3. ACWUAQ156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWUAQ156 route product structure diagram
    ACWUAQ156174060-40-3
Inquiry

Comments (0)